Clinical decision thresholds for surfactant administration in preterm infants: a systematic review and network meta-analysis

[1]  J. Miletin,et al.  Thresholds for surfactant use in preterm neonates: a network meta-analysis , 2022, Archives of Disease in Childhood.

[2]  Binbin Guo,et al.  Lung Ultrasound for the Diagnosis and Management of Neonatal Respiratory Distress Syndrome: A Minireview , 2022, Frontiers in Pediatrics.

[3]  T. Bandyopadhyay,et al.  Interventions to Prevent Bronchopulmonary Dysplasia in Preterm Neonates: An Umbrella Review of Systematic Reviews and Meta-analyses. , 2022, JAMA pediatrics.

[4]  J. Carlin,et al.  Effect of Minimally Invasive Surfactant Therapy vs Sham Treatment on Death or Bronchopulmonary Dysplasia in Preterm Infants With Respiratory Distress Syndrome: The OPTIMIST-A Randomized Clinical Trial. , 2021, JAMA.

[5]  C. Rüegger,et al.  Surfactant Nebulization to Prevent Intubation in Preterm Infants: A Systematic Review and Meta-analysis , 2021, Pediatrics.

[6]  C. Roehr,et al.  Addressing the Lack of Clarity About Administering Surfactant in Preterm Infants With Respiratory Distress Syndrome Treated With Noninvasive Respiratory Support. , 2021, JAMA pediatrics.

[7]  T. Bandyopadhyay,et al.  Surfactant therapy in late preterm and term neonates with respiratory distress syndrome: a systematic review and meta-analysis , 2021, Archives of Disease in Childhood.

[8]  P. Krajewski,et al.  FiO2 Before Surfactant, but Not Time to Surfactant, Affects Outcomes in Infants With Respiratory Distress Syndrome , 2021, Frontiers in Pediatrics.

[9]  Love Kumar Sah,et al.  Less Invasive Surfactant Administration (LISA) vs. Intubation Surfactant Extubation (InSurE) in Preterm Infants with Respiratory Distress Syndrome: A Pilot Randomized Controlled Trial. , 2021, Journal of tropical pediatrics.

[10]  M. Shokouhi,et al.  Comparison of minimally invasive surfactant therapy with intubation surfactant administration and extubation for treating preterm infants with respiratory distress syndrome: a randomized clinical trial , 2021, Clinical and experimental pediatrics.

[11]  P. Davis,et al.  Surfactant therapy via thin catheter in preterm infants with or at risk of respiratory distress syndrome. , 2021, The Cochrane database of systematic reviews.

[12]  Jacqueline A. Gallup,et al.  Randomized Trial of Surfactant Therapy via Laryngeal Mask Airway vs. Brief Tracheal Intubation , 2021, Section on Neonatal-Perinatal Medicine Program.

[13]  V. Shah,et al.  Guidelines for surfactant replacement therapy in neonates. , 2021, Paediatrics & child health.

[14]  Yong Yang,et al.  Lung recruitment improves the efficacy of intubation-surfactant-extubation treatment for respiratory distress syndrome in preterm neonates, a randomized controlled trial , 2021, BMC Pediatrics.

[15]  R. Panza,et al.  Comparative efficacy of methods for surfactant administration: a network meta-analysis , 2021, Archives of Disease in Childhood.

[16]  W. Göpel,et al.  Developmental outcome of extremely preterm infants is improved after less invasive surfactant application: Developmental outcome after LISA , 2020, Acta paediatrica.

[17]  J. Rodríguez-Fanjul,et al.  Early surfactant replacement guided by lung ultrasound in preterm newborns with RDS: the ULTRASURF randomised controlled trial , 2020, European Journal of Pediatrics.

[18]  F. Cools,et al.  Lung recruitment before surfactant administration in extremely preterm neonates with respiratory distress syndrome (IN-REC-SUR-E): a randomised, unblinded, controlled trial. , 2020, The Lancet. Respiratory medicine.

[19]  Bijan Saha,et al.  Minimally invasive surfactant therapy versus InSurE in preterm neonates of 28 to 34 weeks with respiratory distress syndrome on non-invasive positive pressure ventilation—a randomized controlled trial , 2020, European Journal of Pediatrics.

[20]  Xue-feng Zhang,et al.  Minimally Invasive Surfactant Administration for the Treatment of Neonatal Respiratory Distress Syndrome: A Multicenter Randomized Study in China , 2020, Frontiers in Pediatrics.

[21]  W. Göpel,et al.  Two-year outcome data suggest that less invasive surfactant administration (LISA) is safe. Results from the follow-up of the randomized controlled AMV (avoid mechanical ventilation) study , 2020, European Journal of Pediatrics.

[22]  M. Hei,et al.  Effects of less invasive surfactant administration (LISA) via a gastric tube on the treatment of respiratory distress syndrome in premature infants aged 32 to 36 weeks , 2020, Medicine.

[23]  S. Nangia,et al.  A new clinical respiratory distress score for surfactant therapy in preterm infants with respiratory distress , 2019, European Journal of Pediatrics.

[24]  N. Marlow,et al.  Perinatal management of extreme preterm birth before 27 weeks of gestation: a framework for practice , 2020, Archives of Disease in Childhood.

[25]  H. Dalili,et al.  Surfactant Administration in Preterm Neonates Using Laryngeal Mask Airway: A Randomized Clinical Trial , 2019 .

[26]  Aakash Pandita,et al.  Surfactant therapy in premature babies: SurE or InSurE , 2019, Pediatric pulmonology.

[27]  G. Maamouri,et al.  Comparative study of the effect of the administration of surfactant through a thin endotracheal catheter into trachea during spontaneous breathing with intubation (intubation-surfactant-extubation method) , 2019, Journal of Clinical Neonatology.

[28]  Natalie S Blencowe,et al.  RoB 2: a revised tool for assessing risk of bias in randomised trials , 2019, BMJ.

[29]  S. Kheiri,et al.  A Comparative Study of the Efficacy of Surfactant Administration through a Thin Intratracheal Catheter and its Administration via an Endotracheal Tube in Neonatal Respiratory Distress Syndrome , 2018 .

[30]  J. Pillow,et al.  Nebulised surfactant to reduce severity of respiratory distress: a blinded, parallel, randomised controlled trial , 2018, Archives of Disease in Childhood: Fetal and Neonatal Edition.

[31]  L. Lehtonen,et al.  Respiratory Management of Extremely Preterm Infants: An International Survey , 2018, Neonatology.

[32]  N. Finer,et al.  Laryngeal Mask Airway for Surfactant Administration in Neonates: A Randomized, Controlled Trial , 2017, The Journal of pediatrics.

[33]  A. C. Simões e Silva,et al.  A randomized controlled trial of the laryngeal mask airway for surfactant administration in neonates. , 2017, Jornal de pediatria.

[34]  A. Julien,et al.  Efficacy of minimally invasive surfactant therapy in moderate and late preterm infants: A multicentre randomized control trial. , 2017, Paediatrics & child health.

[35]  Hossam M. Hammady,et al.  Rayyan—a web and mobile app for systematic reviews , 2016, Systematic Reviews.

[36]  J. Beyene,et al.  Association of Noninvasive Ventilation Strategies With Mortality and Bronchopulmonary Dysplasia Among Preterm Infants: A Systematic Review and Meta-analysis. , 2016, JAMA.

[37]  J. Pinheiro,et al.  Randomized trial of laryngeal mask airway versus endotracheal intubation for surfactant delivery , 2016, Journal of Perinatology.

[38]  W. Göpel,et al.  Nonintubated Surfactant Application vs Conventional Therapy in Extremely Preterm Infants: A Randomized Clinical Trial. , 2015, JAMA pediatrics.

[39]  S. McDonald,et al.  Noninvasive Ventilation With vs Without Early Surfactant to Prevent Chronic Lung Disease in Preterm Infants: A Systematic Review and Meta-analysis. , 2015, JAMA pediatrics.

[40]  Kristian Thorlund,et al.  The PRISMA Extension Statement for Reporting of Systematic Reviews Incorporating Network Meta-analyses of Health Care Interventions: Checklist and Explanations , 2015, Annals of Internal Medicine.

[41]  Jiajun Zhu,et al.  A pilot study of less invasive surfactant administration in very preterm infants in a Chinese tertiary center , 2015, BMC Pediatrics.

[42]  M. Mohammadizadeh,et al.  Early administration of surfactant via a thin intratracheal catheter in preterm infants with respiratory distress syndrome: Feasibility and outcome , 2015, Journal of research in pharmacy practice.

[43]  Joseph Beyene,et al.  Network Meta-Analysis Using R: A Review of Currently Available Automated Packages , 2014, PloS one.

[44]  Mohammad Hassan Murad,et al.  A GRADE Working Group approach for rating the quality of treatment effect estimates from network meta-analysis , 2014, BMJ : British Medical Journal.

[45]  M. Mohammadizadeh,et al.  A comparison of surfactant administration through i-gel and ET-tube in the treatment of respiratory distress syndrome in newborns weighing more than 2000 grams , 2014, Advanced biomedical research.

[46]  N. Uraş,et al.  Early regular versus late selective poractant treatment in preterm infants born between 25 and 30 gestational weeks: a prospective randomized multicenter study , 2014, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.

[47]  I. Mahmoud,et al.  Comparison of Nasal Continuous Positive Airway Pressure Therapy with and without Prophylactic Surfactant in Preterm Neonates , 2013 .

[48]  H. Stanchev,et al.  Early Surfactant Guided by Lamellar Body Counts on Gastric Aspirate in Very Preterm Infants , 2013, Neonatology.

[49]  M. Heidarzadeh,et al.  Surfactant Administration via Thin Catheter during Spontaneous Breathing: Randomized Controlled Trial in Alzahra hospital , 2013 .

[50]  Gorm Greisen,et al.  European Consensus Guidelines on the Management of Neonatal Respiratory Distress Syndrome in Preterm Infants - 2013 Update , 2013, Neonatology.

[51]  U. Dilmen,et al.  Surfactant Administration via Thin Catheter During Spontaneous Breathing: Randomized Controlled Trial , 2013, Pediatrics.

[52]  Praveen Kumar,et al.  Early Routine versus Late Selective Surfactant in Preterm Neonates with Respiratory Distress Syndrome on Nasal Continuous Positive Airway Pressure: A Randomized Controlled Trial , 2012, Neonatology.

[53]  J. Kattwinkel,et al.  Administration of Rescue Surfactant by Laryngeal Mask Airway: Lessons from a Pilot Trial , 2012, American Journal of Perinatology.

[54]  J. Tapia,et al.  Randomized trial of early bubble continuous positive airway pressure for very low birth weight infants. , 2012, The Journal of pediatrics.

[55]  W. Göpel,et al.  Avoidance of mechanical ventilation by surfactant treatment of spontaneously breathing preterm infants (AMV): an open-label, randomised, controlled trial , 2011, The Lancet.

[56]  Georgia Salanti,et al.  Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial. , 2011, Journal of clinical epidemiology.

[57]  Michele Tarsilla.  Cochrane Handbook for Systematic Reviews of Interventions , 2010, Journal of MultiDisciplinary Evaluation.

[58]  Abhik Das,et al.  Early CPAP versus surfactant in extremely preterm infants. , 2010, The New England journal of medicine.

[59]  R. Hentschel,et al.  Neurodevelopmental outcome and pulmonary morbidity two years after early versus late surfactant treatment: does it really differ? , 2009, Acta paediatrica.

[60]  M. Laughon,et al.  Very Early Surfactant Without Mandatory Ventilation in Premature Infants Treated With Early Continuous Positive Airway Pressure: A Randomized, Controlled Trial , 2009, Pediatrics.

[61]  H. Halliday,et al.  Surfactants: past, present and future , 2008, Journal of Perinatology.

[62]  C. D’Angio,et al.  Surfactant Administration by Transient Intubation in Infants 29 to 35 Weeks' Gestation with Respiratory Distress Syndrome Decreases the Likelihood of Later Mechanical Ventilation: A Randomized Controlled Trial , 2005, Journal of Perinatology.

[63]  C. Dani,et al.  Early extubation and nasal continuous positive airway pressure after surfactant treatment for respiratory distress syndrome among preterm infants <30 weeks' gestation. , 2004, Pediatrics.

[64]  B. Morris,et al.  Early surfactant for neonates with mild to moderate respiratory distress syndrome: a multicenter, randomized trial. , 2004, The Journal of pediatrics.

[65]  F. Vaz,et al.  Clinical course of premature infants intubated in the delivery room, submitted or not to porcine-derived lung surfactant therapy within the first hour of life , 2003, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.

[66]  B. Winbladh,et al.  Pilot study of nebulized surfactant therapy for neonatal respiratory distress syndrome , 2000, Acta paediatrica.

[67]  G. Greisen,et al.  Nasal continuous positive airway pressure and early surfactant therapy for respiratory distress syndrome in newborns of less than 30 weeks' gestation. , 1999, Pediatrics.

[68]  R. Hentschel,et al.  Early Versus Late Surfactant Treatment in Preterm Infants of 27 to 32 Weeks' Gestational Age: A Multicenter Controlled Clinical Trial , 1998, Pediatrics.

[69]  H. Walti,et al.  Porcine surfactant replacement therapy in newborns of 25‐31 weeks’gestation: a randomized, multicentre trial of prophylaxis versus rescue with multiple low doses , 1995, Acta paediatrica.

[70]  G. Greisen,et al.  Surfactant therapy and nasal continuous positive airway pressure for newborns with respiratory distress syndrome. Danish-Swedish Multicenter Study Group. , 1994, The New England journal of medicine.

[71]  J. D. de Winter,et al.  Comparison of prophylaxis and rescue treatment with Curosurf in neonates less than 30 weeks' gestation: a randomized trial. , 1993, Pediatrics.

[72]  The Coronis Collaborative Group.  Early versus delayed neonatal administration of a synthetic surfactant — the judgment of OSIRIS , 1992, The Lancet.

[73]  S. Chida,et al.  A prospective, randomized trial of early versus late administration of a single dose of surfactant-TA. , 1992, Early human development.

[74]  D. Phelps,et al.  A Comparison of Surfactant as Immediate Prophylaxis and as Rescue Therapy in Newborns of Less Than 30 Weeks?? Gestation , 1991 .

[75]  G. Heldt,et al.  Randomized, placebo-controlled trial of human surfactant given at birth versus rescue administration in very low birth weight infants with lung immaturity. , 1991, The Journal of pediatrics.

[76]  D. Phelps,et al.  A comparison of surfactant as immediate prophylaxis and as rescue therapy in newborns of less than 30 weeks' gestation. , 1991, The New England journal of medicine.

[77]  F. Possmayer,et al.  Bovine surfactant replacement therapy in neonates of less than 30 weeks' gestation: a randomized controlled trial of prophylaxis versus treatment. , 1991, Pediatrics.

[78]  L. Papile,et al.  Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birth weights less than 1,500 gm. , 1978, The Journal of pediatrics.

[79]  R. Radfar,et al.  Comparing the Efficacy of Surfactant Administration by Laryngeal Mask Airway and Endotracheal Intubation in Neonatal Respiratory Distress Syndrome , 2018 .

[80]  Xu-fang Li 李旭芳,et al.  Effects of different surfactant administrations on cerebral autoregulation in preterm infants with respiratory distress syndrome , 2016, Journal of Huazhong University of Science and Technology [Medical Sciences].

[81]  F. Nayeri,et al.  Comparison of INSURE method with conventional mechanical ventilation after surfactant administration in preterm infants with respiratory distress syndrome: therapeutic challenge. , 2014, Acta medica Iranica.

[82]  Ming-Yu Li,et al.  [Clinical effectiveness of INSURE method in the treatment of neonatal respiratory distress syndrome]. , 2013, Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics.

[83]  J. Higgins,et al.  Cochrane Handbook for Systematic Reviews of Interventions, Version 5.1.0. The Cochrane Collaboration , 2013 .

[84]  P. Mohagheghi,et al.  DO LARGE PRETERM INFANTS WITH RESPIRATORY DISTRESS SYNDROME BENEFIT FROM EARLY SURFACTANT , 2008 .

[85]  S. Ainsworth.  Pathophysiology of Neonatal Respiratory Distress Syndrome , 2005, Treatments in respiratory medicine.

[86]  R. Bejar,et al.  Outcome at twelve months of adjusted age in very low birth weight infants with lung immaturity: a randomized, placebo-controlled trial of human surfactant. , 1993, The Journal of pediatrics.